Gene Therapy on Neurological Diseases Market was valued at USD 7.5 Billion in 2022 and is projected to reach USD 29.4 Billion by 2030, growing at a CAGR of 19.0% from 2024 to 2030.
The gene therapy market for neurological diseases experienced significant growth in 2022, with the market size reaching approximately USD 3.4 billion. This sector has been expanding at a robust Compound Annual Growth Rate (CAGR) of 25.8%, reflecting heightened investment in innovative treatments and technological advancements. The increasing prevalence of neurological disorders, coupled with growing research and development activities, has been a driving force behind this impressive growth. The rising adoption of gene therapy approaches to address complex neurological conditions, such as Parkinson’s disease, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS), contributes to the overall market expansion.
Opportunity analysis for this market indicates a promising future, with substantial growth prospects projected for the coming years. Emerging markets, particularly in regions with developing healthcare infrastructure, are expected to provide significant opportunities for market players. The rising number of clinical trials, coupled with advancements in gene-editing technologies and increasing healthcare expenditure, is likely to fuel further market growth. Additionally, strategic collaborations and partnerships between pharmaceutical companies and research institutions are anticipated to enhance the development and commercialization of gene therapies for neurological diseases, thereby bolstering market opportunities globally.
Get an In-Depth Research Analysis of the Global Gene Therapy on Neurological Diseases Market Size And Forecast [2025-2032]
Biogen
Novartis
Sarepta Therapeutics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Gene Therapy on Neurological Diseases Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Gene Therapy on Neurological Diseases Market
Hospital
Clinic
Other
Based on Types the Market is categorized into Below types that held the largest Gene Therapy on Neurological Diseases market share In 2023.
Viral Gene Therapy
Non-viral Gene Therapy
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Gene Therapy on Neurological Diseases Market Research Analysis
1. Introduction of the Global Gene Therapy on Neurological Diseases Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Gene Therapy on Neurological Diseases Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Gene Therapy on Neurological Diseases Market, By Type
6. Global Gene Therapy on Neurological Diseases Market, By Application
7. Global Gene Therapy on Neurological Diseases Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Gene Therapy on Neurological Diseases Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/